D-106
Today
2025.01.29
Abstract
Submission Guideline
  • Submission Guideline
  • Presentation Guideline
  • Grants & Awards
Submission Guideline
Important Dates
  • Deadline for Abstract Submission
    January 16, 2025
  • Notification of Abstract Acceptance
    February 18, 2025
Online Submission
Abstract Submission Guideline
  • All abstracts must be submitted via the Online System only.
  • The abstract submitter must choose one topic from the category.
  • Submitting an abstract does not automatically register you for KCR 2025. Please ensure that all abstract presenters also complete the registration process.
  • Authors can modify their abstracts before the submission deadline (January 16 (Thu.), 2025) on the website.
  • When you submit your abstract online, your abstract will be automatically edited according to KCR 2025 submission formats.
  • It is the authors' responsibility to review the submissions and correct them. Submitters are responsible for all typing errors in the abstract.
  • The submission form is intended for the review of the abstract.
  • A confirmation letter of abstract submission will be automatically sent to the submitter and corresponding author by e-mail upon the completion of the online submission.
Encore Presentation
  • An encore presentation is one where you have already presented the submitted work before.
  • Encore presentations are permitted as long as work has been presented after the last KCR (May 16 (Thu.) – 18 (Sat.), 2024) when you have presented the work at another academic conference.
  • Encore presentations are permitted as long as work has not previously been published prior to submission.
  • Publication in a print or online journal of the abstract in a scientific journal after the submission deadline is not in conflict with presenting it at KCR 2025.
  • Abstracts published before the abstract review or posted in online journals cannot be submitted.
  • When the abstract is found that it has been published or posted in an online journal before the abstract review, it will be excluded from the review.
  • Encore submissions must disclose the name and date of the meeting at which they were presented if they are updated or enhanced (e.g. added number or method of analysis, etc.).
  • Encore submissions must disclose the name and date of the meeting at which they were presented if they are updated or enhanced such as added number or method of analysis, etc. (e.g. "This abstract was presented previously in ACR 2023 conference, at Oct - 2023.").
Embargo Policy
  • Communication and/or dissemination of abstracts and information contained therein intended for presentations and/or lectures at the KCR 2025 is prohibited during the embargo period, i.e. starting from the date of acceptance notice until the start of each individual presentation. After the presentation, KCR will allow dissemination and submission to any other third party.
  • KCR 2025’s permission is required prior to dissemination and/or submission to any other third party. In case of any violation of the above-stated policies, KCR 2025, the copyright holder, reserves the right to take appropriate action, including withdrawal of the concerned abstract.
Conflict of Interest Disclosure
If there are relevant financial activities outside the submitted work, the submitter, who is entrusted by all the co-authors, must complete a disclosure form for potential conflict of interest when they submit their abstract. A conflict of interest may exist when an author (or author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or abstract. Please fill out the Conflict-of-Interest Disclosure Form and send it to the KCR 2025 Secretariat via email, program@kcr2025.com.
Conflict of Interest Disclosure Form
Guidelines for Submission
Language English Only
Presentation Type 1) Original Article (Oral or Poster)
2) Case Report (Poster)
Title Only the first letter of the title should start with a capital letter, except for proper nouns.
Format
Original Research – Oral or Poster
Background/Objective - Methods - Results - Conclusion
Case Report – Poster Only
Introduction – Case Report - Discussion
Length Title: Up to 30 words
Body: Up to 300 words
Figure & Table Only 1 figure & 1 table is allowed.
* No more than 1 picture, table, graph, or figure should be included in a file.
Keywords Up to three keywords
Funding Source (Optional) If you have any funding source to disclose, please state it in ‘Funding Source’ section.
Topic Categories
1 Basic Science and Immunology Related to Rheumatic Diseases 9 Pain in Rheumatic Disease Including Fibromyalgia
2 Crystal Arthropathies 10 Pediatric Rheumatology
3 Epidemiology & Public Health 11 Rheumatoid Arthritis
4 Miscellaneous Inflammatory Diseases 12 Sjögren's Syndrome
5 Muscle Biology, Myositis and Myopathies 13 Spondyloarthritis Including Psoriatic Arthritis
6 Orthopedics, Low Back Pain, and Rehabilitation 14 Systemic Lupus Erythematosus and Antiphospholipid Syndrome
7 Osteoarthritis 15 Systemic Sclerosis and Related Disorders Including Raynaud's Phenomenon 
8 Osteoporosis and Metabolic Bone Disease 16 Vasculitis Including ANCA-associated and Behcet Disease 
Abstract Review & Notification of Result
All submitted abstracts will be reviewed by the scientific committee according to the review process.
The topic category can be changed after the review by the Scientific Committee.
Authors can submit abstracts for Oral and Poster. However, the final presentation type of the accepted abstract is under the discretion of the scientific committee. (Case reports will be presented by Poster Only.)
The acceptance notice of abstracts will be notified via e-mail to the presenting author and corresponding author by no later than February 28 (Mon.), 2025.
Registration for Presenters
The presenting author whose abstract has been accepted needs to register with full payment for the meeting to confirm their participation.
If the presenting author does not register by the registration deadline, the abstract will be automatically withdrawn from the final program.
If the presenter does not attend the congress or present the abstract without any notification to the KCR 2025 Secretariat in advance, there will be disadvantages in participating in future meetings.
Withdrawal Policy
If you would like to withdraw an abstract, please fill out the “Withdrawal Request Form” and send it by e-mail to the KCR 2025 Secretariat (program@kcr2025.com).
If the presenter of the accepted abstract does not register by the deadline for Early Bird Registration, April 16 (Wed.), 2025, the abstract will be automatically withdrawn from the final program.
Withdrawal Request Form
Contact for Abstract Submission
KCR 2025 Secretariat  |  
Tel. +82-2-6278-8591  |